Medication

Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…

Vance finds critical support for a 2028 presidential run at a conservative conference. The FDA approves a pill…

Wetin we call dis foto, Ellen and Tanya both lose weight with GLP-1 drugs, but dem get very…

It was launched in June due to increased demand on health services from people using the class B…

LONDON, Dec 23 (Reuters) – Novo Nordisk’s newly approved weight-loss pill version of Wegovy will be a test…

WHO Global Summit charts a bold future for traditional medicine World Health Organization (WHO)‘A potential treasure trove’: World Health…

BBC Keith Lawrence was diagnosed with ADHD online by a private clinic based in England Almost 4,000 prescriptions…

Australia’s medicine watchdog has issued another safety warning for three unapproved Ayurvedic medicines found with “extremely high” amounts…

New Delhi: Medicines in India may get cheaper following a significant drop in the prices of active pharmaceutical…

US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy,…

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug…

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made…

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)